CommentOutbreak of multidrug-resistant tuberculosis on Daru Island
References (15)
- et al.
Burden of transmitted multidrug resistance in epidemics of tuberculosis: a transmission modelling analysis
Lancet Respir Med
(2015) Australian law could silence critics of refugee health
Lancet Respir Med
(2016)- et al.
Will Ebola change the game? Ten essential reforms before the next pandemic. The report of the Harvard-LSHTM Independent Panel on the Global Response to Ebola
Lancet
(2015) - et al.
Timebomb: the global epidemic of multidrug-resistant tuberculosis
(2001) - Hiasihri S, Aia P, John NL, et al. Primary transmission of drug-resistant tuberculosis in South Fly District, Western...
- et al.
TB incidence and characteristics in the remote gulf province of Papua New Guinea: a prospective study
BMC Infect Dis
(2014) - et al.
Diversity of Mycobacterium tuberculosis and drug resistance in different provinces of Papua New Guinea
BMC Microbiol
(2014)
Cited by (18)
Ebola Virus Epidemic in West Africa: Global Health Economic Challenges, Lessons Learned, and Policy Recommendations
2017, Value in Health Regional IssuesCitation Excerpt :We examine the response to the latest EVD outbreak in West Africa, identify direct and indirect treatment costs to treat the patient from a public health system perspective, present key economic challenges and lessons learned, and highlight policy recommendations to further assist an already stretched health system in Africa. There were institutional failures of some international organizations that had grave consequences for global health in Sri Lanka in 2009, Haiti in 2010, South Sudan in 2013, and the multidrug-resistant tuberculosis response in Papua New Guinea at present [5,6]. It is important to reconsider how the global health architecture should be reshaped to allow for greater assurance of global health and to prevent future health crises.
The risk of global epidemic replacement with drug-resistant Mycobacterium tuberculosis strains
2017, International Journal of Infectious DiseasesCitation Excerpt :In contrast, the highest proportions of isolates showing drug resistance are found in Eastern Europe, with 32% and 76% of new and previously treated cases, respectively, found to be MDR-TB in Belarus.29 However, the true global incidence of MDR-TB is unknown, the proportion of new cases tested for drug susceptibility is only 12% globally,1 and MDR-TB is spreading in countries with the poorest surveillance systems; for example, the incidence of MDR-TB may be as high as 1000 per 100 000 population in Daru, Papua New Guinea.30 On the basis of early evidence of the variable and slow emergence of multidrug resistance decades after the introduction of therapy, many argued that MDR-TB would not replace DS-TB.31
Outbreak of multidrug-resistant tuberculosis on Daru Island: an update
2016, The Lancet Respiratory MedicineAntimicrobial resistance threatening animal-human health in Papua New Guinea
2023, Australian Zoologist